Agreements

www.nureca.com Date: June 20, 2026 1. National Stock Exchange of India Limited 2. BSE Limited Listing Department, Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, P J Towers, Dalal Street, Bandra (E), Mumbai 400 051 Mumbai 400 001 Symbol: NURECA Scrip Code: 543264 Ref.: Disclosure under Regulation 30 and Regulation 30A read with Clauses 5 and 5A of Para A of Part A of Schedule III of Securities and Exchange Board of India (“SEBI”) (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulation”) Sub.: Intimation of Family Settlement Agreement Dear Sir/Madam, The Company (Nureca Limited) has received a communication dated June 19, 2026 from certain members of the Promoter/ Promoter Group regarding execution of a Family Settlement Agreement ("FSA") dated June 17, 2026. The Company is not a party to the said FSA. The Company has not independently verified the contents of the FSA and is making this disclosure solely based on information furnished by the concerned Promoter/ Promoter Group for compliance with Regulation 30A of the LODR Regulations. The details as required under LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (“Master Circular”), are provided in Annexure A. Kindly take the same on record. Yours faithfully, For Nureca Limited Nishu Kansal Company Secretary & Compliance Officer M.No. A33372 NURECA LIMITED Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009 Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS, Andheri West, Mumbai – 400053 Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868 www.nureca.com ANNEXURE A Disclosure under Regulation 30A read with Clause 5A of Para A of Part A of Schedule III of the LODR Regulations: Sr. Particulars Disclosure 1 If the listed entity is a party to the Not applicable. The listed entity, i.e., Nureca agreement, i. details of the Limited (“Company”), is not a party to Family counterparties (including name and Settlement Agreement (“FSA”). relationship with the listed entity). 2 i. Name(s) of parties to the agreement The Family Settlement Agreement ("FSA") has been entered into amongst:  Mr. Saurabh Goyal, being sole promoter and Ms. Smita Goyal, being part of promoters group, on one part; and  Mr. Aryan Goyal and Ms. Payal Goyal, being part of promoters group, on other part. ii. Relationship of parties with the listed The parties are members of the promoter and/or entity promoter Group of the Company. iii. Date of execution of agreement June 17, 2026 3 Purpose of the agreement The FSA has been entered into for family settlement, succession planning, allocation/re- alignment of ownership interests in properties, management responsibilities and settlement of inter-se rights amongst promoter and promoters g roup family members. 4 Shareholding, if any, in the entity with The Company is not a Party to FSA. whom the agreement is executed The Shareholding of parties is provided as per Appendix 1. 5 Significant terms of the agreement (in The FSA has been entered into for family brief) settlement, succession planning, allocation/re- alignment of ownership interests in properties, management responsibilities and settlement of inter-se rights amongst promoter and promoters group family members. In relation to the Company, under FSA, after fulfilling certain conditions mentioned therein:  It is proposed that Mr. Aryan Goyal and his wife Mrs. Payal Goyal will transfer all their shares in the Company to Mr. Saurabh Goyal.  Further Mr. Aryan Goyal will step down from the position of CEO and will also resign and c ease to be the director of the Company. NURECA LIMITED Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009 Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS, Andheri West, Mumbai – 400053 Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868 www.nureca.com 6 Extent and the nature of impact on Mr. Saurabh Goyal is presently the Chairman & management or control of the listed Managing Director and sole promoter of the entity Company and already exercise control over the affairs of the Company. Accordingly, the proposed transaction does not result in acquisition of fresh control. However, since the transaction results in a substantial increase in his individual voting rights beyond 50%, an alternative interpretation may be that the transaction further strengthens his existing control position. In either event, Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (“SAST Regulations”) grants exemption from the obligations under both Regulation 3 and Regulation 4 of SAST Regulations. 7 Details and quantification of the Nil. restriction or liability imposed upon the listed entity The FSA does not impose any obligation, liability, restriction or commitment upon the Company. 8 Whether, the said parties are related to Please see response to sr. no. (2) above. promoter/promoter group/ group companies in any manner. If yes, nature of relationship 9 Whether the transaction would fall Not applicable. within related party transactions? If yes, whether the same is done at “arm’s The FSA has been entered into among the above length” mentioned members of the promoter/ promoter group family inter-se and the Company is not party to the same. 10 In case of issuance of shares to the Not applicable. parties, details of issue price, class of shares issued 11 Any other disclosures related to such Not applicable. agreements, viz., details of nominee on the board of directors of the listed entity, For details, please see response to sr. no. (5) potential conflict of interest arising out of above. s uch agreements, etc. 12 Any other material information The disclosure is being made based on information received from the concerned Promoters pursuant to Regulation 30A of the LODR Regulations. The Company has not independently verified the contents of the FSA. Any consequential changes in shareholding, NURECA LIMITED Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009 Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS, Andheri West, Mumbai – 400053 Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868 www.nureca.com promoter classification, control, management or governance rights shall be disclosed separately as and when they occur. 13 In case of rescission, amendment or Not applicable. alteration, listed entity shall disclose additional details to the stock exchange(s): i. name of parties to the agreement; ii. nature of the agreement; iii. date of execution of the agreement; iv. details and reasons for amendment or alteration and impact thereof (including impact on management or control and on the restriction or liability quantified earlier); v. reasons for rescission and impact thereof (including impact on management or control and on the restriction or liability quantified earlier). NURECA LIMITED Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009 Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS, Andheri West, Mumbai – 400053 Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868 www.nureca.com Appendix 1 Sr. Name Category of Pre Inter se Transfer Post Inter se Transfer Difference shareholder Total no. Total as Total no. Total as shares a % of shares a % of held Total held Total Voting Voting right right 1 SAURABH Promoter 32,78,056 34.35 64,97,169 68.09 33.74 GOYAL 2 SMITA Promoter 7 0.00 7 0.00 - GOYAL Group 3 PAYAL Promoter 20,59,928 21.59 0 - -21.59 GOYAL Group 4 ARYAN Promoter 11,59,185 12.15 0 - -12.15 GOYAL Group 5 PUBLIC Public 30,44,744 31.91 30,44,744 31.91 - Grand Total 95,41,920 100.00 95,41,920 [Showing first 8,000 characters — download PDF for full document]